Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma is a research paper published in Blood (2020). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA175313
NCRR NIH HHS
Grant: S10 RR027050
NHLBI NIH HHS
Grant: R01 HL093716
NIH HHS
Grant: S10 OD020056
NCATS NIH HHS
Grant: UL1 TR001873
FWCI
0.80
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals